Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

AZD2906

Name: AZD2906
Brand: TargetMol
SKU: T14374
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T14374Cas No. 1034148-15-6

AZD2906, a selective glucocorticoid receptor (GR) agonist, demonstrates inhibitory concentrations (IC50s) of 2.2 nM in human GR, 0.3 nM in rat peripheral blood mononuclear cells (PBMC), 41.6 nM in human whole blood, and 7.5 nM in rat whole blood, respectively[1]. Additionally, it induces an increase in micronucleated immature erythrocytes within rat bone marrow.

AZD2906

Copy Product Info

😃Good

Catalog No. T14374Cas No. 1034148-15-6

Pack Size	Price	USA Warehouse	Global Warehouse
5 mg	$427	6-8 weeks	6-8 weeks
25 mg	$1,400	6-8 weeks	6-8 weeks
50 mg	$1,820	6-8 weeks	6-8 weeks
100 mg	$2,500	6-8 weeks	6-8 weeks

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	AZD2906, a selective glucocorticoid receptor (GR) agonist, demonstrates inhibitory concentrations (IC50s) of 2.2 nM in human GR, 0.3 nM in rat peripheral blood mononuclear cells (PBMC), 41.6 nM in human whole blood, and 7.5 nM in rat whole blood, respectively[1]. Additionally, it induces an increase in micronucleated immature erythrocytes within rat bone marrow.
Targets&IC50	GR (rat PBMC):0.3 nM, GR (human whole blood):41.6 nM, GR (human PBMC):2.2 nM, GR (rat whole blood):7.5 nM
In vitro	AZD2906 is a selective glucocorticoid receptor (GR) with IC50 values of 2.2 nM and 0.3 nM in human and rat PBMC, and 41.6 nM and 7.5 nM in human and rat whole blood, respectively[1].
In vivo	AZD2906 (5, 25, 50 mg/kg, p.o.) increases micronucleated immature erythrocytes (MIE) in the bone marrow of rats after 2 days of treatment and induces glycogen accumulation in the liver at 5 and 25 mg/kg, p.o., while causing moderate to marked cortical lymphocytic atrophy in the thymus of rats[1].

Chemical Properties

Molecular Weight	460.5
Formula	C₂₆H₂₅FN₄O₃
Cas No.	1034148-15-6
Smiles	COc1ccc(cn1)[C@@H](Oc1ccc2n(ncc2c1)-c1ccc(F)cc1)[C@H](C)NC(=O)C1CC1
Relative Density.	1.33 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 125 mg/mL (271.44 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (7.17 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.1716 mL	10.8578 mL	21.7155 mL	108.5776 mL
5 mM	0.4343 mL	2.1716 mL	4.3431 mL	21.7155 mL
10 mM	0.2172 mL	1.0858 mL	2.1716 mL	10.8578 mL
20 mM	0.1086 mL	0.5429 mL	1.0858 mL	5.4289 mL
50 mM	0.0434 mL	0.2172 mL	0.4343 mL	2.1716 mL
100 mM	0.0217 mL	0.1086 mL	0.2172 mL	1.0858 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc